127
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder

, , &
Received 12 Feb 2024, Accepted 16 May 2024, Published online: 23 May 2024

References

  • Anderson, B. T., Danforth, A., Daroff, P. R., Stauffer, C., Ekman, E., Agin-Liebes, G., Trope, A., Boden, M. T., Dilley, P. J., Mitchell, J., & Woolley, J. (2020). Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine, 27, 100538. https://doi.org/10.1016/j.eclinm.2020.100538
  • Balk, D. E. (1999). Bereavement and spiritual change. Death Studies, 23(6), 485–493. https://doi.org/10.1080/074811899200849
  • Bardideh, F., Jarareh, J., Mofrad, M., & Bardideh, K. (2022). The effectiveness of integrated group therapy on prolonged grief disorder of bereaved people from COVID-19 randomized controlled trial. Omega, 302228221141126. https://doi.org/10.1177/00302228221141126
  • Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. (2016). The challenging experience questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England), 30(12), 1279–1295. https://doi.org/10.1177/0269881116678781
  • Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015). Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England), 29(11), 1182–1190. https://doi.org/10.1177/0269881115609019
  • Biancalani, G., Azzola, C., Sassu, R., Marogna, C., & Testoni, I. (2022). Spirituality for coping with the trauma of a loved one’s death during the COVID-19 pandemic: An Italian qualitative study. Pastoral Psychology, 71(2), 173–185. https://doi.org/10.1007/s11089-021-00989-8
  • Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., Rotrosen, J., Tonigan, J. S., & Worth, L. (2022). Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 79(10), 953–962. https://doi.org/10.1001/jamapsychiatry.2022.2096
  • Breeksema, J. J., Kuin, B. W., Kamphuis, J., van den Brink, W., Vermetten, E., & Schoevers, R. A. (2022). Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of Psychopharmacology (Oxford, England), 36(10), 1100–1117. https://doi.org/10.1177/02698811221116926
  • Damianakis, T., & Marziali, E. (2012). Older adults’ response to the loss of a spouse: The function of spirituality in understanding the grieving process. 16, 57–66. https://doi.org/10.1080/13607863.2011.609531
  • Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489. https://doi.org/10.1001/jamapsychiatry.2020.3285
  • Djelantik, A. A. A. M. J., Robinaugh, D. J., Kleber, R. J., Smid, G. E., & Boelen, P. A. (2020). Symptomatology following loss and trauma: Latent class and network analyses of prolonged grief disorder, posttraumatic stress disorder, and depression in a treatment-seeking trauma-exposed sample. Depression and Anxiety, 37(1), 26–34. https://doi.org/10.1002/da.22880
  • Eisma, M. C. (2023). Prolonged grief disorder in ICD-11 and DSM-5-TR: Challenges and controversies. The Australian and New Zealand Journal of Psychiatry, 57(7), 944–951. https://doi.org/10.1177/00048674231154206
  • Eisma, M. C., Boelen, P. A., & Lenferink, L. I. M. (2020). Prolonged grief disorder following the Coronavirus (COVID-19) pandemic. Psychiatry Research, 288, 113031. https://doi.org/10.1016/j.psychres.2020.113031
  • Family, N., Hendricks, P. S., Williams, L. T., Luke, D., Krediet, E., Maillet, E. L., & Raz, S. (2022). Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology (Oxford, England), 36(3), 321–336. https://doi.org/10.1177/02698811211069103
  • Folkman, S. (1997). Positive psychological states and coping with severe stress. Social Science & Medicine (1982), 45(8), 1207–1221. https://doi.org/10.1016/s0277-9536(97)00040-3
  • Gang, J., Kocsis, J., Avery, J., Maciejewski, P. K., & Prigerson, H. G. (2021). Naltrexone treatment for prolonged grief disorder: Study protocol for a randomized, triple-blinded, placebo-controlled trial. Trials, 22(1), 110. https://doi.org/10.1186/s13063-021-05044-8
  • Golden, A. M. J., & Dalgleish, T. (2010). Is prolonged grief distinct from bereavement-related posttraumatic stress? Psychiatry Research, 178(2), 336–341. https://doi.org/10.1016/j.psychres.2009.08.021
  • González, D., Aixalà, M. B., Neimeyer, R. A., Cantillo, J., Nicolson, D., & Farré, M. (2022). Restorative retelling for processing psychedelic experiences: Rationale and case study of complicated grief. Frontiers in Psychology, 13, 832879. https://doi.org/10.3389/fpsyg.2022.832879
  • González, D., Cantillo, J., Pérez, I., Farré, M., Feilding, A., Obiols, J. E., & Bouso, J. C. (2020). Therapeutic potential of ayahuasca in grief: A prospective, observational study. Psychopharmacology, 237(4), 1171–1182. https://doi.org/10.1007/s00213-019-05446-2
  • González, D., Carvalho, M., Cantillo, J., Aixalá, M., & Farré, M. (2017). Potential use of ayahuasca in grief therapy. 79, 260–285. https://doi.org/10.1177/0030222817710879
  • Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. (2019). Survey of subjective ‘God encounter experiences’: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS One, 14(4), e0214377. https://doi.org/10.1371/journal.pone.0214377
  • Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England), 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513
  • Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018). Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England), 32(1), 49–69. https://doi.org/10.1177/0269881117731279
  • Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England), 22(6), 621–632. https://doi.org/10.1177/0269881108094300
  • Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. https://doi.org/10.1007/s00213-006-0457-5
  • Gukasyan, N., Davis, A. K., Barrett, F. S., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., & Griffiths, R. R. (2022). Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology (Oxford, England), 36(2), 151–158. https://doi.org/10.1177/02698811211073759
  • Hayes, A. M., Yasinski, C., Grasso, D., Ready, C. B., Alpert, E., McCauley, T., Webb, C., & Deblinger, E. (2017). Constructive and unproductive processing of traumatic experiences in trauma-focused cognitive-behavioral therapy for youth. Behavior Therapy, 48(2), 166–181. https://doi.org/10.1016/j.beth.2016.06.004
  • Heeke, C., Stammel, N., Heinrich, M., & Knaevelsrud, C. (2017). Conflict-related trauma and bereavement: Exploring differential symptom profiles of prolonged grief and posttraumatic stress disorder. BMC Psychiatry, 17(1), 118–110. https://doi.org/10.1186/s12888-017-1286-2
  • Johnson, M. W., Garcia-Romeu, A., Johnson, P. S., & Griffiths, R. R. (2017). An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology (Oxford, England), 31(7), 841–850. https://doi.org/10.1177/0269881116684335
  • Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019). Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics, 197, 83–102. https://doi.org/10.1016/j.pharmthera.2018.11.010
  • Jordan, A. H., & Litz, B. T. (2014). Prolonged grief disorder: Diagnostic, assessment, and treatment considerations. Professional Psychology: Research and Practice, 45, 180–187. https://doi.org/10.1037/a0036836
  • Kakarala, S. E., Roberts, K. E., Rogers, M., Coats, T., Falzarano, F., Gang, J., Chilov, M., Avery, J., Maciejewski, P. K., Lichtenthal, W. G., & Prigerson, H. G. (2020). The neurobiological reward system in Prolonged Grief Disorder (PGD): A systematic review. Psychiatry Res Neuroimaging, 303, 111135. https://doi.org/10.1016/j.pscychresns.2020.111135
  • Kentish-Barnes, N., Chaize, M., Seegers, V., Legriel, S., Cariou, A., Jaber, S., Lefrant, J.-Y., Floccard, B., Renault, A., Vinatier, I., Mathonnet, A., Reuter, D., Guisset, O., Cohen-Solal, Z., Cracco, C., Seguin, A., Durand-Gasselin, J., Éon, B., Thirion, M., … Azoulay, É. (2015). Complicated grief after death of a relative in the intensive care unit. The European Respiratory Journal, 45(5), 1341–1352. https://doi.org/10.1183/09031936.00160014
  • Kersting, A., Brähler, E., Glaesmer, H., & Wagner, B. (2011). Prevalence of complicated grief in a representative population-based sample. Journal of Affective Disorders, 131, 339–343. https://doi.org/10.1016/j.jad.2010.11.032
  • Kristensen, P., Dyregrov, K., & Dyregrov, A. (2017). What distinguishes prolonged grief disorder from depression? Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke, 137(7), 538–539. https://doi.org/10.4045/tidsskr.16.0629
  • Laperle, P., Achille, M., & Ummel, D. (2022). The relational landscape of bereavement after anticipated death: An interpretive model. Death Studies, 46(10), 2485–2497. https://doi.org/10.1080/07481187.2021.1975177
  • Linde, K., Treml, J., Steinig, J., Nagl, M., & Kersting, A. (2017). Grief interventions for people bereaved by suicide: A systematic review. PLoS One, 12(6), e0179496. https://doi.org/10.1371/journal.pone.0179496
  • Low, F., & Earleywine, M. (2023). Psychedelic experiences after bereavement improve symptoms of grief: The influence of emotional breakthroughs and challenging experiences. Journal of Psychoactive Drugs, 1–8. https://doi.org/10.1080/02791072.2023.2228303
  • Lundorff, M., Holmgren, H., Zachariae, R., Farver-Vestergaard, I., & O’Connor, M. (2017). Prevalence of prolonged grief disorder in adult bereavement: A systematic review and meta-analysis. Journal of Affective Disorders, 212, 138–149. https://doi.org/10.1016/j.jad.2017.01.030
  • MacArthur, N. D., Kirby, E., & Mowll, J. (2023). Bereavement affinities: A qualitative study of lived experiences of grief and loss. Death Studies, 47(7), 836–846. https://doi.org/10.1080/07481187.2022.2135044
  • MacLean, K. A., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. (2012). Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin. Journal for the Scientific Study of Religion, 51(4), 721–737. https://doi.org/10.1111/j.1468-5906.2012.01685.x
  • Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G, M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., … Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025–1033. https://doi.org/10.1038/s41591-021-01336-3
  • Mitchell, J. M., Ot’alora G, M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., Hamilton, S., Mithoefer, M., Kleiman, S., Parker-Guilbert, K., Tzarfaty, K., Harrison, C., de Boer, A., Doblin, R., & Yazar-Klosinski, B. (2023). MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial. Nature Medicine, 29(10), 2473–2480. https://doi.org/10.1038/s41591-023-02565-4
  • Montgomery, C., & Roberts, C. A. (2022). Neurological and cognitive alterations induced by MDMA in humans. Experimental Neurology, 347, 113888. https://doi.org/10.1016/j.expneurol.2021.113888
  • Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. (2017). Tripping up addiction: The use of psychedelic drugs in the treatment of problematic drug and alcohol use. Current Opinion in Behavioral Sciences, 13, 71–76. https://doi.org/10.1016/j.cobeha.2016.10.009
  • Muttoni, S., Ardissino, M., & John, C. (2019). Classical psychedelics for the treatment of depression and anxiety: A systematic review. Journal of Affective Disorders, 258, 11–24. https://doi.org/10.1016/j.jad.2019.07.076
  • Nautiyal, K. M., & Yaden, D. B. (2023). Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects. Neuro­psychopharmacology: official Publication of the American College of Neuropsychopharmacology, 48(1), 215–216. https://doi.org/10.1038/s41386-022-01424-z
  • New meanings of death. Retrieved from https://psycnet.apa.org/record/1978-08140-000
  • Oconnor, M. F. (2012). Immunological and neuroimaging biomarkers of complicated grief. Dialogues in Clinical Neuroscience, 14, 141–148. https://doi.org/10.31887/DCNS.2012.14.2/mfoconnor
  • Papa, A., Sewell, M. T., Garrison-Diehn, C., & Rummel, C. (2013). A randomized open trial assessing the feasibility of behavioral activation for pathological grief responding. Behavior Therapy, 44(4), 639–650. https://doi.org/10.1016/j.beth.2013.04.009
  • Prigerson, H. G., & Maciejewski, P. K. (2022). Prolonged grief disorder. The Lancet. Psychiatry, 9(9), 696. https://doi.org/10.1016/S2215-0366(22)00263-2
  • Prigerson, H. G., Boelen, P. A., Xu, J., Smith, K. V., & Maciejewski, P. K. (2021). Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-revised (PG-13-R) scale. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 20(1), 96–106. https://doi.org/10.1002/wps.20823
  • Prigerson, H. G., Maciejewski, P. K., Reynolds, C. F. 3rd, Bierhals, A. J., Newsom, J. T., Fasiczka, A., Frank, E., Doman, J., & Miller, M. (1995). Inventory of complicated grief: A scale to measure maladaptive symptoms of loss. Psychiatry Research, 59, 65–79. https://doi.org/10.1016/0165-1781(95)02757-2
  • Prigerson, H. G., Bierhals, A. J., Kasl, S. V., Reynolds, C. F. III, Shear, M. K., Day, N., Beery, L. C., Newsom, J. T., & Jacobs, S. (1997). Traumatic grief as a risk factor for mental and physical morbidity. The American Journal of Psychiatry, 154, 616–623.
  • Prigerson, H. G., Frank, E., Kasl, S. V., Reynolds, C. F., Anderson, B., Zubenko, G. S., Houck, P. R., George, C. J., & Kupfer, D. J. (1995). Complicated grief and bereavement-related depression as distinct disorders: Preliminary empirical validation in elderly bereaved spouses. The American Journal of Psychiatry, 152(1), 22–30.
  • Prigerson, H. G., Horowitz, M. J., Jacobs, S. C., Parkes, C. M., Aslan, M., Goodkin, K., Raphael, B., Marwit, S. J., Wortman, C., Neimeyer, R. A., Bonanno, G. A., Block, S. D., Kissane, D., Boelen, P., Maercker, A., Litz, B. T., Johnson, J. G., First, M. B., & Maciejewski, P. K. (2009). Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11. PLoS Medicine, 6(8), e1000121. https://doi.org/10.1371/journal.pmed.1000121
  • Prigerson, H. G., Kakarala, S., Gang, J., & Maciejewski, P. K. (2021). History and status of prolonged grief disorder as a psychiatric diagnosis. Annual Review of Clinical Psychology, 17(1), 109–126. https://doi.org/10.1146/annurev-clinpsy-081219-093600
  • Prigerson, H. G., Shear, M. K., & Reynolds, C. F. (2022). Prolonged grief disorder diagnostic criteria—Helping those with maladaptive grief responses. JAMA Psychiatry, 79(4), 277–278. https://doi.org/10.1001/jamapsychiatry.2021.4201
  • Ransome, Y. (2020). Religion, spirituality, and health: New considerations for epidemiology. American Journal of Epidemiology, 189(8), 755–758. https://doi.org/10.1093/aje/kwaa022
  • Rappaport, B. I., Kandala, S., Luby, J. L., & Barch, D. M. (2020). Brain reward system dysfunction in adolescence: Current, cumulative, and developmental periods of depression. The American Journal of Psychiatry, 177(8), 754–763. https://doi.org/10.1176/appi.ajp.2019.19030281
  • Reynolds, C. F., Miller, M. D., Pasternak, R. E., Frank, E., Perel, J. M., Cornes, C., Houck, P. R., Mazumdar, S., Dew, M. A., & Kupfer, D. J. (1999). Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. The American Journal of Psychiatry, 156, 202–208. https://doi.org/10.1176/ajp.156.2.202
  • Richardson, V. E. (2006). A dual process model of grief counseling. Journal of Gerontological Social Work, 48, 311–329. https://doi.org/10.1300/J083v48n03_03
  • Rosner, R., Pfoh, G., & Kotoučová, M. (2011). Treatment of complicated grief, 2, 7995. https://doi.org/10.3402/ejpt.v2i0.7995
  • Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology (Oxford, England), 30(12), 1165–1180. https://doi.org/10.1177/0269881116675512
  • Shear, M. K. (2015). Clinical practice. Complicated grief. The New England Journal of Medicine, 372(2), 153–160. https://doi.org/10.1056/NEJMcp1315618
  • Shear, M. K., Reynolds, C. F., Simon, N. M., Zisook, S., Wang, Y., Mauro, C., Duan, N., Lebowitz, B., & Skritskaya, N. (2016). Optimizing treatment of complicated grief: A randomized clinical trial. JAMA Psychiatry, 73(7), 685–694. https://doi.org/10.1001/jamapsychiatry.2016.0892
  • Shear, M. K., Wang, Y., Skritskaya, N., Duan, N., Mauro, C., & Ghesquiere, A. (2014). Treatment of complicated grief in elderly persons: A randomized clinical trial. JAMA Psychiatry, 71(11), 1287–1295. https://doi.org/10.1001/jamapsychiatry.2014.1242
  • Smith, K. W., Sicignano, D. J., Hernandez, A. V., & White, C. M. (2022). MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review with meta-analysis. Journal of Clinical Pharmacology, 62(4), 463–471. https://doi.org/10.1002/jcph.1995
  • Spillers, C. S. (2007). An existential framework for understanding the counseling needs of clients. American Journal of Speech-Language Pathology, 16(3), 191–197. https://doi.org/10.1044/1058-0360(2007/024)
  • Steenkamp, M. M., Litz, B. T., Hoge, C. W., & Marmar, C. R. (2015). Psychotherapy for military-related PTSD: A review of randomized clinical trials. JAMA, 314(5), 489–500. https://doi.org/10.1001/jama.2015.8370
  • Thompson, E. H., Noone, M. E., & Guarino, A. B. (2003). Widows’ spiritual journeys: Do they quest? Journal of Religion, Spirituality & Aging, 14, 119–138.
  • Volkow, N. D., Michaelides, M., & Baler, R. (2019). The neuroscience of drug reward and addiction. Physiological Reviews, 99(4), 2115–2140. https://doi.org/10.1152/physrev.00014.2018
  • Wagner, B., Knaevelsrud, C., & Maercker, A. (2006). Internet-based cognitive-behavioral therapy for complicated grief: A randomized controlled trial. Death Studies, 30(5), 429–453. https://doi.org/10.1080/07481180600614385
  • Walsh, K., King, M., Jones, L., Tookman, A., & Blizard, R. (2002). Spiritual beliefs may affect outcome of bereavement: Prospective study. BMJ (Clinical Research ed.), 324(7353), 1551–1551. https://doi.org/10.1136/bmj.324.7353.1551
  • Wenn, J. A., O’Connor, M., Kane, R. T., Rees, C. S., & Breen, L. J. (2015). Efficacy of metacognitive therapy for prolonged grief disorder: Protocol for a randomised controlled trial. BMJ Open, 9(1), e007221. https://doi.org/10.1136/bmjopen-2017-021409
  • Yaden, D. B., & Griffiths, R. R. (2021). The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacology & Translational Science, 4(2), 568–572. https://doi.org/10.1021/acsptsci.0c00194
  • Yaden, D. B., & Newberg, A. (2022). The varieties of spiritual experience: 21st century research and perspectives. Oxford University Press. https://doi.org/10.1093/OSO/9780190665678.001.0001
  • Yaden, D. B. ,Giorgi, S. ,Kern, M. L. ,Adler, A. ,Ungar, L. H. ,Seligman, M. E. P., & Eichstaedt, J. C. (2021). Beyond beliefs: Multidimensional aspects of religion and spirituality in language. Psychology of Religion and Spirituality, 15, 272–280.
  • Yaden, D. B., Nayak, S. M., Gukasyan, N., Anderson, B. T., & Griffiths, R. R. (2022). The potential of psychedelics for end of life and palliative care. Current Topics in Behavioral Neurosciences, 56, 169–184. https://doi.org/10.1007/7854_2021_278
  • Zisook, S., & Shear, K. (2009). Grief and bereavement: what psychiatrists need to know. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 8(2), 67–74. https://doi.org/10.1002/j.2051-5545.2009.tb00217.x
  • Zygmont, M., Prigerson, H. G., Houck, P. R., Miller, M. D., Shear, M. K., Jacobs, S., & Reynolds, C. F. (1998). A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. The Journal of Clinical Psychiatry, 59(5), 241–245. https://doi.org/10.4088/jcp.v59n0507

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.